[Results of a clinico-experimental study of the preparation Galidor in the treatment of chronic coronary insufficiency].
D000787:Angina Pectoris / Q000517:prevention & control*; D000818:Animals; D003327:Coronary Disease / Q000188:drug therapy*; D003508:Cycloheptanes / Q000627:therapeutic use*; D004285:Dogs; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000150:complications; D009206:Myocardium / Q000378:metabolism; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D010208:Papaverine / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use*; D013166:Spondylitis / Q000150:complications
D003508:Cycloheptanes; D010276:Parasympatholytics; D010208:Papaverine
Rezul'taty kliniko-éksperimental'nogo izucheniia preparata galidor pri lechenii khronicheskoĭ koronarnoĭ nedostatochnosti.